Trial Profile
Effect of interferon/ribavirin/telaprevir therapy on innate and adaptive immune response in patients with chronic hepatitis C.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 16 Dec 2015 New trial record